Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Exosurf Neonatal and Survanta for the Treatment of Respiratory Distress Syndrome

NCT01203358 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01203358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Exosurf Neonatal and Survanta for the Treatment of Respiratory Distress Syndrome
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 1991
Completion date
January 31, 1992
Enrollment
617 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, infant, low birth weight, infant, newborn, infant, premature, infant, small for gestational age